Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Viprovex
- Development stage
- Preclinical
- Lead developer
- ImmuneRegen BioSciences
- Modality
- Peptides
- Administration
- Intranasal, Inhalation
01
Overview
Viprovex is a synthetic peptide immunomodulator developed by ImmuneRegen BioSciences, a subsidiary of IR BioSciences Holdings. It is a specific formulation of Homspera, which is a derivative of the naturally occurring neuropeptide Substance P (specifically the analog Sar9, Met-Substance P). Viprovex is designed to enhance the immune system and improve pulmonary function, acting as a homeostatic compound. It has been investigated as a medical countermeasure for bioterrorism threats and for the treatment of various viral and bacterial infections, including influenza and acute melioidosis. Pre-clinical research has demonstrated that Viprovex, when used in combination with oseltamivir (Tamiflu), can provide enhanced protection against lung inflammation caused by influenza infection compared to oseltamivir alone.
- Brand names
- Viprovex
- Other names
- HomsperaSar9, Met-Substance P
02
Targets
TACR1 (Neurokinin‑1 Receptor)
Beyond the preview
Go deeper on Viprovex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Viprovex.